NEW YORK (GenomeWeb) – Thermo Fisher Scientific this week declared a quarterly cash dividend of $.15 per share, payable on Oct. 16 to shareholders of record as of Sept. 15.


Helix announced this week that its DNA sequencing laboratory has been accredited by the College of American Pathologists. Helix received CLIA accreditation in 2015. The company operates a next-generation sequencing laboratory in San Diego where it offers a proprietary sequencing assay called Exome+.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Penn State Hershey Medical Center staffer has admitted to lying about skipping mandatory steps of genetic cancer tests he performed, the Associated Press reports.

The genome of a rare, red bat suggests that its effective population size has been in decline for thousands of years, according to a PLOS One study.

In Nature this week: investigation into the genetics of medulloblastoma, and more.

A project in the UK is to use genomic selection to speed spruce tree growth, according to Innovators Magazine.